Chikage Kakuta
Overview
Explore the profile of Chikage Kakuta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Washida K, Saito S, Tanaka T, Nakaoku Y, Ishiyama H, Abe S, et al.
Cereb Circ Cogn Behav
. 2024 Feb;
6:100211.
PMID: 38375188
Background: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), the most common form of hereditary cerebral small vessel disease (SVD), currently lacks disease-modifying treatments. Adrenomedullin (AM), a vasoactive...
2.
Saito S, Suzuki K, Ohtani R, Maki T, Kowa H, Tachibana H, et al.
JAMA Netw Open
. 2023 Dec;
6(12):e2344938.
PMID: 38048134
Importance: Recent evidence indicates the efficacy of β-amyloid immunotherapy for the treatment of Alzheimer disease, highlighting the need to promote β-amyloid removal from the brain. Cilostazol, a selective type 3...
3.
Egashira S, Tanaka K, Oka A, Nagasawa Y, Kohama K, Tokunaga A, et al.
Rinsho Shinkeigaku
. 2023 Apr;
63(5):275-285.
PMID: 37100621
The 16-Item Informant Questionnaire on Cognitive Decline for the Elderly (IQCODE 16) has been frequently used to diagnose prestroke dementia, an important determinant of stroke prognosis. We developed the Japanese...
4.
Cui C, Higashiyama A, Lopresti B, Ihara M, Aizenstein H, Watanabe M, et al.
Brain Sci
. 2021 Sep;
11(9).
PMID: 34573201
The Alzheimer's Disease Neuroimaging Initiative showed that Japanese had significantly lower brain Aβ burden than Americans among a cognitively normal population. This cross-sectional study aimed to compare vascular disease burden,...
5.
Sekikawa A, Higashiyama A, Lopresti B, Ihara M, Aizenstein H, Watanabe M, et al.
Alzheimers Dement (N Y)
. 2020 Oct;
6(1):e12089.
PMID: 33117881
Introduction: Equol, a metabolite of a soy isoflavone transformed by the gut microbiome, is anti-oxidant and anti-amyloidogenic. We assessed the associations of equol with white matter lesion normalized to total...
6.
Cui C, Birru R, Snitz B, Ihara M, Kakuta C, Lopresti B, et al.
Nutr Rev
. 2019 Sep;
78(2):134-144.
PMID: 31504836
Context: The results of preclinical and observational studies support the beneficial effect of soy isoflavones on cognition. Objective: This review aimed to evaluate the effects of soy isoflavones on cognition...
7.
Sekikawa A, Ihara M, Lopez O, Kakuta C, Lopresti B, Higashiyama A, et al.
Curr Cardiol Rev
. 2018 Dec;
15(2):114-135.
PMID: 30516108
Background: Observational studies in Asia show that dietary intake of soy isoflavones had a significant inverse association with coronary heart disease (CHD). A recent randomized controlled trial (RCT) of soy...
8.
Nagano J, Kakuta C, Motomura C, Odajima H, Sudo N, Nishima S, et al.
Biopsychosoc Med
. 2010 Oct;
4:12.
PMID: 20929533
Objective: To examine relationships between a mother's stress-related conditions and parenting attitudes and their children's asthmatic status. Methods: 274 mothers of an asthmatic child 2 to 12 years old completed...